Last reviewed · How we verify

NCT05256251: We-Longevity

Westlake Longevity Cohort

Recruiting now Last updated 15 June 2025
What this trial tests

trial in Aging in 1,500 participants. Currently enrolling.

Timeline
15 November 2021
Primary endpoint
14 November 2025
14 November 2031

Quick facts

Lead sponsorWestlake University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,500
Start date15 November 2021
Primary completion14 November 2025
Estimated completion14 November 2031
Sites1 location across China

Conditions studied

Sponsor

Westlake University

Who can join

Eligibility, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians and senior citizens living in Lishui, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. The second aim is to culture the gut microbiota of these elderly people through culturomics. The third aim of We-Longevity is to investigate the association of dietary and lifestyle with the multi-omics molecular characteristics of healthy longevity, and to facilitate the development of personalized nutritional/lifestyle recommendation for the public.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Westlake University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05256251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing